Cymabay Therapeutics Inc (NASDAQ: CBAY) Has Another Chance To Impress You
Currently, there are 113.40M common shares owned by the public and among those 107.98M shares have been available to trade. Insiders at the company have transacted a total of 62 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 31 of these insider trades were purchases, […]
Is There More Upside Ahead For Cymabay Therapeutics Inc (NASDAQ: CBAY)
BlackRock Fund Advisors has recently announced that it has increased stake in Cymabay Therapeutics Inc (NASDAQ:CBAY) by 5.53%. After grabbing 7.0 million shares, the institutional investor is now in possession of 0.37 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 6.17% having worth around $133.88 million. Moreover, […]
Cymabay Therapeutics Inc (NASDAQ: CBAY): Do Not Miss The Gain Train
BlackRock Fund Advisors has recently announced that it has increased stake in Cymabay Therapeutics Inc (NASDAQ:CBAY) by 5.53%. After grabbing 7.0 million shares, the institutional investor is now in possession of 0.37 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 6.21% having worth around $114.63 million. Moreover, […]
